Assessing clinical and functional outcomes in the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial

Schizophrenia Bulletin

Volumn 29, Issue 1, 2003, Pages 33-43

  Swartz, Marvin S ^a   Perkins, Diana O ^b   Stroup, T Scott ^b   McEvoy, Joseph P ^a   Nieri, Jennifer M ^b   Haak, David C ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Functional assessment; Outcome measures; Psychopathology assessment; Schizophrenia treatment

Indexed keywords

NEUROLEPTIC AGENT;

AKATHISIA; AKINESIA; CLINICAL TRIAL; COMMUNITY; CONSTIPATION; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FUNCTIONAL ASSESSMENT; GALACTORRHEA; GYNECOMASTIA; HUMAN; HYPERSALIVATION; HYPERSOMNIA; INCONTINENCE; INSOMNIA; LIBIDO DISORDER; MENSTRUAL IRREGULARITY; MENTAL HEALTH; ORGASM DISORDER; ORTHOSTATIC HYPOTENSION; OUTCOMES RESEARCH; PRIORITY JOURNAL; RASH; REVIEW; SCHIZOPHRENIA; SEXUAL AROUSAL; SIDE EFFECT; SOMNOLENCE; SYMPTOM; SYNCOPE; TARDIVE DYSKINESIA; TRAINING; URINARY HESITANCY; WEIGHT GAIN; XEROSTOMIA;

EID: 0037771503     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a006989     Document Type: Review

References (41)

1. Addington, D.; Addington, J.; and Atkinson, M. A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Schizophrenia Research, 19:205-212, 1996.
2. Addington, D.; Addington, J.; and Maticka-Tyndale, E. Specificity of the Calgary Depression Scale for schizophrenics. Schizophrenia Research, 11:239-244, 1994.
3. Addington, D.; Addington, J.; Maticka-Tyndale, E.; and Joyce, J. Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research, 6:201-208, 1992.
4. Addington, D.; Addington, J.; and Schissel, B. A depression rating scale for schizophrenics. Schizophrenia Research, 3:247-251, 1990.
5. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: APA, 1994.
6. Awad, A.G.; Vomganti, L.; and Heslegrave, R.J. A conceptual model of quality of life in schizophrenia: Description and preliminary clinical validation. Quality of Life Research, 6:21-26, 1997.
7. Barnes, T.R. A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154:672-676, 1989.
8. Bell, M.; Milstein, R.; Beam-Goulet, J.; Lysaker, P.; and Cicchetti, D. The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale: Reliability, comparability, and predictive validity. Journal of Nervous and Mental Disease, 180:723-728, 1992.
9. Creer, C.; Sturt, E.; and Wykes, T. The role of relatives. In: Wing, J.K., ed. Long-Term Community Care: Experiences in a London Borough. Psychological Medicine, Monograph Suppl. 2, 1982.
10. Drake, R.; Osher, F.C.; Noordsy, D.L.; Hurlbut, S.C.; Teague, G.B.; and Beaudett, M.S. Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin, 16(1):57-67, 1990.
11. Edson, R.; Lavori, P.; Tracy, K.; Adler, L.A.; and Rotrosen, J. Interrater reliability issues in multicenter trials: II. Statistical procedures used in Department of Veterans Affairs Cooperative Study #394. Psychopharmacology Bulletin, 33:59-67, 1997.
12. First, M.B.; Spitzer, R.L.; Gibbon, M.; and Williams, J.B.W. Structured Clinical Interview for DSM-IV (SCID-I) (User's Guide and Interview) Research Version. New York, NY: Biometrics Research Department, New York Psychiatric Institute, 1995.
13. Franks, D.D. Economic contribution of families caring for persons with severe and persistent mental illness. Administration and Policy in Mental Health, 18:9-18, 1990.
14. Guy, W. ECDEU Assessment Manual for Psychopharmacology - Revised. DHEW Publication No. ADM 76-338. Rockville, MD: U.S. Department of Health, Education, and Welfare; Public Health Service; Alcohol, Drug Abuse, and Mental Health Administration; NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976.
15. Heinrichs, D.W.; Hanlon, T.E.; and Carpenter, W.T. The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10(3):388-396, 1984.
16. Hogan, T.P., and Awad, A.G. Subjective response to neuroleptics and outcome in schizophrenia: A re-examination comparing two measures. Psychological Medicine, 22:347-352, 1992.
17. Hogan, T.P.; Awad, A.G; and Eastwood, R. A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine, 13:177-183, 1983.
18. Igarashi, Y.; Hayashi, N.; Yamashina, M.; Otsuka, N.; Kuroki, N.; Anzai, N.; and Kazamatsuri, H. Interrater reliability of the Japanese version of the Positive and Negative Syndrome Scale and the appraisal of its training effect. Psychiatry and Clinical Neurosciences, 52:467-468, 1998.
19. Kay, S.R.; Fiszbein, A.; and Opler, L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2):261-276, 1987.
20. Kay, S.R.; Opler, L.A.; and Lindenmayer, J.P. The Positive and Negative Syndrome Scale (PANSS): Rationale and standardisation. British Journal of Psychiatry, 7(Suppl):59-67, 1989.
21. Kelly, G.R.; Mannon, J.A.; and Scott, J.E. Utility of the health belief model and examining medication compliance among psychiatric outpatients. Social Science and Medicine, 25:1205-1211, 1987.
22. Lehman, A.F. Measuring QOL in a reformed health system. Health Affairs, 45:91-101, 1995.
23. Lehman, A.F., and Burns, B.J. Severe mental illness in the community. In: Spiker B., ed. Quality of Life Assessment in Clinical Trials. New York, NY: Raven Press, 1990. pp. 357-366.
24. McEvoy, J.P.; Apperson L.J.; Appelbaum, P.S.; Ortlip, P.; Brecosky, J.; Hammill, K.; Geller, J.L.; and Roth, L. Insight in schizophrenia: Its relationship to acute psychopathology. Journal of Nervous and Mental Disease, 177:43-47, 1989.
25. Müller, M.J.; Rossbach, W.; Dannigkeit, P.; Müller-Siecheneder, F.; Szegedi, A.; and Wetzel, H. Evaluation of standardized rater training for the Positive and Negative Syndrome Scale (PANSS). Schizophrenia Research, 32:151-160, 1998.
26. Müller, M.J., and Wetzel, H. Improvement of interrater reliability of PANSS items and subscales by standardized rater training. Acta Psychiatrica Scandinavica, 98:135-139, 1998.
27. Norman, R.M.; Malla, A.K.; Cortese, L.; and Diaz, F. A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS. Schizophrenia Research, 19:73-85, 1996.
28. Perkins, D.O.; Wyatt, R.J., and Bartko, J.J. Penny-wise and pound-foolish: The impact of measurement error on sample size requirements in clinical trials. Biological Psychiatry, 47:762-766, 2000.
29. Rosenberg, S.D.; Drake, R.E.; Wolford, G.L.; Mueser, K.T.; Oxman, T.E.; Vidaver, R.M.; Carrieri, K.L.; and Luckoor, R. Dartmouth Assessment of Lifestyle Instrument (DALI): A substance use disorder screen for people with severe mental illness. American Journal of Psychiatry, 155:232-238, 1998.
30. Sachdev, P. A rating scale for acute drug-induced akathisia: Development, reliability, and validity. Biological Psychiatry, 35:263-271, 1994.
31. Salyers, M.P.; McHugo, G.J.; Cook, J.A.; Razzano, L.A.; Drake, R.E.; and Mueser, K.T. Reliability of instruments in a cooperative, multisite study: Employment Intervention Demonstration Program. Mental Health Services Research, 3:129-139, 2001.
32. Segal, D.L.; Hersen, M.; and Van Hasselt, V.B. Reliability of the Structured Clinical Interview for DSM-III-R: An evaluative review. Comprehensive Psychiatry, 35:316-327, 1994.
33. Skre, I.; Onstad, S.; Torgersen, S.; and Kringlen, E. High interrater reliability for the Structured Clinical Interview for DSM-III-R Axis I (SCID-I). Acta Psychiatrica Scandinavica, 84:167-173, 1991.
34. Steadman, H.J.; Mulvey, E.P.; Monahan, J.; Robbins, P.C.; Appelbaum, P.S.; Grisso, T.; Roth, L.H.; and Silver, E. Violence by people discharged from acute inpatient psychiatric facilities and others in the same neighborhoods. Archives of General Psychiatry, 55:393-401, 1998.
35. Swartz, M.S.; Swanson, J.W.; Hiday, V.A.; Borum, R.; Wagner, H.R.; and Burns, B.J. Violence and severe mental illness: The effects of substance abuse and nonadherence to medication. American Journal of Psychiatry, 155:226-231, 1998.
36. Sweet, R.A.; DeSensi, E.G.; and Zubenko, G.S. Reliability and applicability of movement disorder rating scales in the elderly. Journal of Neuropsychiatry and Clinical Neurosciences, 5:56-60, 1993.
37. Tracy, K.; Adler, L.A.; Rotrosen, J.; Edson, R.; and Lavori, P. Interrater reliability issues in multicenter trials: I. Theoretical concepts and operational procedures in VA Cooperative Study #394. Psychopharmacology Bulletin, 33:53-57, 1997.
38. Ventura, J.; Liberman, R.P.; Green, M.F.; Shaner, A.; and Mintz, J. Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Research, 79:163-173, 1998.
39. Ware, J., Jr.; Kosinski, M.; and Keller, S.D. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34:220-233, 1996.
40. Warshaw, M.G.; Dyck, I.; Allsworth, J.; Stout, R.L.; and Keller, M.B. Maintaining reliability in a long-term psychiatric study: An ongoing inter-rater reliability monitoring program using the longitudinal interval follow-up evaluation. Journal of Psychiatric Research, 35:297-305, 2001.
41. Weiden, P.; Rapkin, B.; Mott, T.; Zygmunt, A.; Goldman, D.; Horvitz-Lennon, M.; and Frances, A. Rating of Medication Influences (ROMI) scale in schizophrenia. Schizophrenia Bulletin, 20(2):297-310, 1994.